2005
DOI: 10.1002/bit.20586
|View full text |Cite
|
Sign up to set email alerts
|

Novel quantitative tools for engineering analysis of hepatocyte cultures in bioartificial liver systems

Abstract: Extracorporeal bioartificial liver devices (BAL) are perhaps among the most promising technologies for the treatment of liver failure, but significant technical challenges remain in order to develop systems with sufficient processing capacity and of manageable size. One key limitation is that during BAL operation, when the device is exposed to plasma from the patient, hepatocytes are prone to accumulate intracellular lipids and exhibit poor liver-specific functions. Based on hepatic intermediary metabolism, we… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
33
0
2

Year Published

2006
2006
2016
2016

Publication Types

Select...
5
3

Relationship

1
7

Authors

Journals

citations
Cited by 32 publications
(35 citation statements)
references
References 46 publications
0
33
0
2
Order By: Relevance
“…One specific application of ES cells is the derivation of a renewable hepatocyte cell source, needed for the development of bioartificial livers (Balis et al, 2002;Chan et al, 2004;Sharma et al, 2005;Shinoda et al, 2006;Shito et al, 2003;Yarmush et al, 1992), environmental biosensors (Otsuka et al, 2004;Sin et al, 2004), and in vitro drug screening systems (Dambach et al, 2005;LeCluyse, 2001). The successful development of these applications lies in expanding a large hepatocyte cell mass.…”
Section: Introductionmentioning
confidence: 99%
“…One specific application of ES cells is the derivation of a renewable hepatocyte cell source, needed for the development of bioartificial livers (Balis et al, 2002;Chan et al, 2004;Sharma et al, 2005;Shinoda et al, 2006;Shito et al, 2003;Yarmush et al, 1992), environmental biosensors (Otsuka et al, 2004;Sin et al, 2004), and in vitro drug screening systems (Dambach et al, 2005;LeCluyse, 2001). The successful development of these applications lies in expanding a large hepatocyte cell mass.…”
Section: Introductionmentioning
confidence: 99%
“…Поэтому для определения распределения субстратных потоков в печени необходимо поставить задачу многокритериального программирования с максимизацией синтеза мочевины и АТФ. Для решения данной задачи в работе использовали метод ε-ограничений [30], который максимизирует основную целевую функцию при ограничениях, накладываемых на дополнительную целевую функцию. Здесь в качестве основной целевой функции использовали скорость продукции АТФ, а в качестве дополнительной -синтез мочевины.…”
Section: выбор целевой функцииunclassified
“…Other examples of the use of multiobjective optimization for process optimization are applications related to the beer fermentation process [122], the citric acid fermentation of Aspergillus niger [14], the production of gluconic acid [123], as well as investigations regarding optimal liver function [124] and the production of oil in the yeast Yarrowia lipolytica [125].…”
Section: Optimization Of Biochemical Processesmentioning
confidence: 99%